Newsletters

RCT shows no effect for AI coach. Livongo ups enrollment rate.

3.06.20

8 min. Read

Strip companies tried to kill Livongo. Sanofi DTx distro.

2.28.20

8 min. Read

FDA asks Congress for new SaMD pathway. Headspace $93M.

2.14.20

6 min. Read

Google’s EHR patient notification idea. Bayer-One Drop. Novartis-Pear.

2.07.20

6 min. Read

M&A multiples. Verily FDA. Hires: Otsuka, Astellas, Sanofi, Sandoz.

1.24.20

4 min. Read

Pear oncology. Omada schizophrenia. Noom’s $247M.

1.17.20

5 min. Read

AstraZeneca DTx. Virgin Pulse takes on Omada.

1.10.20

6 min. Read

When will DTx go DTC like Ro, Hims? Pear early revenue predictions.

1.03.20

5 min. Read

Summing up the Prescription Digital Therapeutics Worldview

12.20.19

4 min. Read

Sanofi CEO calls Onduo “e-commerce”. Express Scripts DHF.

12.13.19

6 min. Read